Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis

mBio(2022)10.1128/mbio.03163-21Source: DataRank Database

Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis is a research paper published in mBio (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

refseq doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.45)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Tammie S. Y. Tam,Katherine S. Ralston ORCID,Hannah W. Miller

Live enrichment

PubMed:35227072 PMC:PMC8941920 OpenAlex:https://openalex.org/W4220655241

HHS | National Institutes of Health

Grant: AI146914

NIAID NIH HHS

Grant: R01 AI146914

National Institutes of Health

Grant: 5R01AI146914-05

The role of Entamoeba histolytica trogocytosis (trogo-: nibble) in the pathogenesis of amoebiasis

Pew Charitable Trusts (Pew)

Pew Charitable Trusts

Khaira Family Experiential Learning Award

Pew Charitable Trusts (Pew)

FWCI

1.45

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.03163-21

publisherhttps://doi.org/10.1128/mbio.03163-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.03163-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35227072

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8941920

Fields of Study

Amoebic Infections and TreatmentsPancreatitis Pathology and TreatmentPediatric Hepatobiliary Diseases and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineAmebiasisCell DeathComplement System ProteinsDysentery, AmebicEntamoeba histolyticaHumansTranscription FactorsTrogocytosis

MeSH Terms

TrogocytosisAmebiasisComplement System ProteinsDysentery, AmebicEntamoeba histolyticaHumansTranscription FactorsCell Death

Keywords

Entamoeba histolyticaAmoebiasisMicrobiologyBiologyImmunologyEntamoebaComplement systemVirologyComplement (music)Immune systemGeneticsGeneComplementImmune EvasionTrogocytosis570610DysenteryBiodefense2.1 Biological and endogenous factorsHumansBiomedical and Clinical SciencesCell DeathAmebiasisComplement System ProteinsMedical microbiologyFoodborne IllnessQR1-502Infectious DiseasesEmerging Infectious DiseasesGood Health and Well BeingBiochemistry and cell biologyDysentery, AmebicDigestive DiseasesInfectionAmebicResearch ArticleTranscription Factors

Sustainable Development Goals

SDG 3: 3. Good health